news releases

Vancouver, British Columbia, November 15, 2011— Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon” or the “Company”) announces today that it has developed a novel pea protein isolate. Burcon has branded this new protein as Peazazz™. Peazazz™ is 100% soluble and transparent in low pH solutions with clean flavour characteristics and is heat stable permitting hot fill applications. Burcon’s Peazazz™ could be used in a variety of healthy and flavourful consumer product applications and should be of interest to companies looking for a great tasting functional alternative plant protein ingredient.

Vancouver, British Columbia, March 4, 2011 — Burcon NutraScience Corporation (TSX – BU) announced today that the company has entered into a license agreement with Archer Daniels Midland Company (“ADM”) for the worldwide production, distribution and sale of Burcon’s CLARISOY® soy protein. CLARISOY is a unique soy protein product that is 100 percent soluble, transparent and very low in viscosity in low pH (acidic) beverages. Use of CLARISOY allows for the production of transparent, protein fortified beverages such as juices, soft drinks and sport drinks in the low pH range.

Vancouver, British Columbia, March 4, 2011 — Burcon NutraScience Corporation (TSX – BU) announced today that the company has amended the license and development agreement between Burcon, Burcon NutraScience (MB) Corp. and Archer Daniels Midland Company (“ADM”) to provide an extended development period for continued research aimed at expanding the commercial value of Puratein® and Supertein™.

Vancouver, British Columbia, March 2, 2011 — Burcon NutraScience Corporation (TSX – BU) announced today that the company has amended the Letter of Intent between Burcon and Archer Daniels Midland Company (the “LOI”) to extend the date for completing a definitive license agreement for Burcon’s CLARISOY® technology until noon hour on March 4, 2011. The stand still/no-shop agreement with ADM, which forms part of the LOI, is equally extended until noon hour on March 4, 2011.

Vancouver, British Columbia, November 15, 2010 — Burcon NutraScience Corporation (TSX – BU) ("Burcon") announced today that, simultaneous to and in conjunction with executing the letter of intent to license CLARISOY® as announced today with Archer Daniels Midland Company (ADM), the two parties have also entered into an agreement amending the license and development agreement made among Burcon, Burcon NutraScience (MB) Corp. and ADM on September 16, 2003 and as amended June 1, 2007 (the "License and Development Agreement").

Vancouver, British Columbia, November 15, 2010 — Burcon NutraScience Corporation (TSX – BU) "Burcon") announced today that it has signed a non-binding letter of intent (the "Letter of Intent") with Archer Daniels Midland Company ("ADM") which details the intention of the two parties to enter into a license agreement pursuant to which Burcon will license (the "License") its CLARISOY® technology to ADM on an exclusive basis to produce, market and sell CLARISOY® soy protein isolates ("CLARISOY®" or the "Products") world-wide (the "Definitive Agreement").

August 30, 2010 — Burcon NutraScience Corporation (TSX – BU) (“Burcon”) announced today that the U.S. Food and Drug Administration (FDA or the Agency) has issued a no objection letter with respect to Puratein® and Supertein™ canola protein isolates.

June 28, 2010 — Burcon is pleased to report on the latest business activities with respect to the commercialization of its CLARISOY® soy protein isolate.

November 3, 2009 — Burcon announced today the publication of a peerreviewed manuscript describing a toxicology study of Supertein™ canola protein isolate.

September 22, 2009 — Burcon is pleased to report on the latest developments with respect to the commercialization of its innovative technologies and in particular, CLARISOY™ soy protein isolate.